Egr-1 is a key regulator of the blood-brain barrier damage induced by meningitic Escherichia coli

Cell Commun Signal. 2024 Jan 17;22(1):44. doi: 10.1186/s12964-024-01488-y.

Abstract

Bacterial meningitis remains a leading cause of infection-related mortality worldwide. Although Escherichia coli (E. coli) is the most common etiology of neonatal meningitis, the underlying mechanisms governing bacterial blood-brain barrier (BBB) disruption during infection remain elusive. We observed that infection of human brain microvascular endothelial cells with meningitic E. coli triggers the activation of early growth response 1 (Egr-1), a host transcriptional activator. Through integrated chromatin immunoprecipitation sequencing and transcriptome analysis, we identified Egr-1 as a crucial regulator for maintaining BBB integrity. Mechanistically, Egr-1 induced cytoskeletal changes and downregulated tight junction protein expression by directly targeting VEGFA, PDGFB, and ANGPTL4, resulting in increased BBB permeability. Meanwhile, Egr-1 also served as a master regulator in the initiation of neuroinflammatory response during meningitic E. coli infection. Our findings support an Egr-1-dependent mechanism of BBB disruption by meningitic E. coli, highlighting a promising therapeutic target for bacterial meningitis.

Keywords: Blood-brain barrier; Early growth response 1; Meningitic E. Coli; Neuroinflammation; Permeability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood-Brain Barrier / microbiology
  • Endothelial Cells / metabolism
  • Escherichia coli
  • Humans
  • Infant, Newborn
  • Meningitis, Bacterial* / metabolism
  • Meningitis, Escherichia coli* / metabolism

Substances

  • EGR1 protein, human